|4Nov 19, 8:36 PM ET

Bejar Rafael 4

4 · Aptose Biosciences Inc. · Filed Nov 19, 2021

Insider Transaction Report

Form 4
Period: 2021-11-19
Bejar Rafael
Chief Medical Officer
Transactions
  • Purchase

    Common Shares

    2021-11-19$2.56/sh+10,000$25,60010,000 total

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4